COSMOS Pharmaceutical Corp.

53
Hold
  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3298400007
JPY
6,552.00
19 (0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
May'25
May'24
May'23
May'22
May'21
May'20
No of Months
12
12
12
12
12
12
Operating Income
10,11,390.00
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
6,84,403.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
10,11,390.00
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
6,84,403.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
254.00
99.00
51.00
52.00
60.00
69.00
General and Administration Expenses
1,72,877.00
1,38,536.00
1,22,807.00
1,07,756.00
99,163.00
93,347.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
9,70,986.00
9,33,487.00
7,97,568.00
7,25,617.00
6,93,277.00
6,55,309.00
Operating Profit (PBDIT) excl Other Income
40,404.00
31,502.00
30,129.00
29,797.00
33,147.00
29,094.00
Other Income
2,500.00
2,497.00
2,894.00
3,313.00
6,957.00
2,564.00
Operating Profit (PBDIT)
65,133.00
53,923.00
50,391.00
48,220.00
53,889.00
45,220.00
Interest
254.00
99.00
51.00
52.00
60.00
69.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
22,229.00
19,924.00
17,368.00
15,110.00
13,785.00
13,562.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
42,372.00
33,719.00
32,773.00
33,048.00
38,596.00
30,402.00
Provision for Tax
11,393.00
9,265.00
8,975.00
9,892.00
11,439.00
8,967.00
Profit After Tax
30,978.00
24,454.00
23,797.00
23,155.00
27,156.00
21,435.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
390.85
308.61
300.48
292.37
342.89
270.65
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2025 is 4.81% vs 16.59% in May 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2025 is 28.26% vs 4.56% in May 2024

stock-summary

Interest

YoY Growth in year ended May 2025 is 156.57% vs 94.12% in May 2024

stock-summary

Profit After Tax

YoY Growth in year ended May 2025 is 26.68% vs 2.76% in May 2024

Compare Profit and Loss Results of COSMOS Pharmaceutical Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
10,11,390.00
12,85,005.00
-2,73,615.00
-21.29%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10,11,390.00
12,85,005.00
-2,73,615.00
-21.29%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
254.00
785.00
-531.00
-67.64%
General and Administration Expenses
1,72,877.00
3,28,008.00
-1,55,131.00
-47.29%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
9,70,986.00
12,48,595.00
-2,77,609.00
-22.23%
Operating Profit (PBDIT) excl Other Income
40,404.00
36,410.00
3,994.00
10.97%
Other Income
2,500.00
5,077.00
-2,577.00
-50.76%
Operating Profit (PBDIT)
65,133.00
67,735.00
-2,602.00
-3.84%
Interest
254.00
785.00
-531.00
-67.64%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
22,229.00
26,248.00
-4,019.00
-15.31%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
42,372.00
26,277.00
16,095.00
61.25%
Provision for Tax
11,393.00
11,938.00
-545.00
-4.57%
Profit After Tax
30,978.00
14,957.00
16,021.00
107.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
390.8532
72.1751
318.68
441.53%
Profit And Loss - Net Sales
Net Sales 10,11,390.00 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 4.81% vs 16.59% in May 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40,404.00 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 28.26% vs 4.56% in May 2024

Profit And Loss - Interest
Interest 254.00 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 156.57% vs 94.12% in May 2024

Profit And Loss - Profit After Tax
Profit After Tax 30,978.00 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 26.68% vs 2.76% in May 2024